In the A549/DDP xenograft tumor model, Western blot analysis revealed that while the total protein levels of PI3K, AKT, and mTOR remained unchanged across all treatment groups, the levels of their phosphorylated forms (p-PI3K, p-AKT, p-mTOR) were notably altered. The gene discussed is AKT1; the disease is neoplasm.